Moreover, PI3K activation did not serve as a predictive marker for the sensitivity of ovarian clear cell carcinoma investigated in Japanese patients cohort to PIK3CA/AKT/mTOR inhibitors [71]. The gene discussed is AKT1; the disease is ovarian clear cell cancer.